Get the Stockscreener App
3.69
12.14%
-0.51
Pre-market:
3.61
-0.08
-2.17%
Calcimedica Inc stock is traded at $3.69, with a volume of 215.54K.
It is down -12.14% in the last 24 hours and up +123.64% over the past month.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
See More
Previous Close:
$4.20
Open:
$4.22
24h Volume:
215.54K
Relative Volume:
3.85
Market Cap:
$51.56M
Revenue:
-
Net Income/Loss:
$-13.59M
P/E Ratio:
-3.4167
EPS:
-1.08
Net Cash Flow:
$-19.79M
1W Performance:
+46.43%
1M Performance:
+123.64%
6M Performance:
+35.16%
1Y Performance:
-12.35%
1-Day Range:
$3.37
$4.22
1-Week Range:
$2.53
$4.22
52-Week Range:
$1.42
$5.97
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica Inc
Sector
Industry
Phone
858-952-5500
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
3.69 | 52.81M | 0 | -13.59M | -19.79M | -1.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Calcimedica Inc Stock (CALC) Latest News
Is CalciMedica Inc. a good long term investmentFree Stock Market Real-Time Monitoring - PrintWeekIndia
CalciMedica Inc. Stock Analysis and ForecastSuperior investment outcomes - jammulinksnews.com
What analysts say about CalciMedica Inc. stockFree Trading Psychology Coaching - jammulinksnews.com
What drives CalciMedica Inc. stock priceExponentially increasing returns - jammulinksnews.com
What makes CalciMedica Inc. stock price move sharplyLow Volatility High Yield Stocks - Newser
CalciMedica, Inc. Stock (CALC) Opinions on Clinical Trial Speculation - Nasdaq
CalciMedica’s Clinical Gambit Reflects Biotech’s High-Risk, High-Reward Reality - Finimize
Director Makes Strategic Move with CalciMedica Stock Purchase - TipRanks
CalciMedica (CALC) officer Roberts buys $5,760 in shares - Investing.com
CalciMedica (CALC) officer Roberts buys $5,760 in shares By Investing.com - Investing.com Nigeria
CalciMedica’s CBO Makes a Strategic Stock Purchase! - TipRanks
CalciMedica (CALC) director Roberts buys $15,809 in stock By Investing.com - Investing.com Nigeria
CalciMedica (CALC) director Roberts buys $15,809 in stock - Investing.com India
CalciMedica Director Eric Roberts Buys 6,500 Shares at $2.43 Each - AInvest
Cambridge Investment Research Advisors Inc. Takes $45,000 Position in CalciMedica Inc. (NASDAQ:CALC) - Defense World
Calcimedica (CALC) CEO Leheny buys $6k in stock - Investing.com India
Calcimedica (CALC) CEO Leheny buys $6k in stock By Investing.com - Investing.com Canada
CalciMedica Director Leheny Rachel Buys 2500 Shares at $2.47 per Share. - AInvest
Why CalciMedica Inc. stock attracts strong analyst attentionFree Stock Selection - Newser
How CalciMedica Inc. stock performs during market volatilityFree Stock Market Analysis Courses - Newser
Hedge Fund and Insider Trading News: Ken Griffin, Scott Bessent, Ray Dalio, Bill Ackman, Warren Buffett, Caxton Associates, Man Group, Calcimedica Inc (CALC), and More - Insider Monkey
CalciMedica Soars 25%—What’s Behind the Volatile Surge? - AInvest
Calcimedica (CALC) director Roberts buys $8k in shares - Investing.com Australia
Calcimedica (CALC) director Roberts buys $8k in shares By Investing.com - Investing.com Canada
Insider Transactions Reported | CalciMedica(CALC)saw insider trading activity on 7/10/2025 - AInvest
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.32%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):